William Annett compensation by year
Insight Molecular Diagnostics Summary Compensation Table · all 3 fiscal years held| Component | FY2017 | FY2018 | FY2019 |
|---|---|---|---|
| Salary | $397,308 | $400,000 | $275,833 |
| Bonus | $40,000 | $220,000 | $73,500 |
| Stock awards | $0 | $0 | — |
| Option awards | $740,276 | $292,058 | $955,545 |
| Non-equity incentive | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $13,500 | $13,750 | $324,000 |
| Total | $1,191,084 | $925,808 | $1,628,878 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Insight Molecular Diagnostics Inc. DEF 14A filed May 26, 2020, accession 0001493152-20-009826, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Insight Molecular Diagnostics Inc. filed document, accession 0001493152-20-009826. Every figure is read from that document and cited to the page and table it appears in. Filed May 26, 2020.
Equity holdings
unvested awards at FY2018 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 75,000 | — | $2.20 |
| Option | 72,916 | — | $3.06 |
| Option | 121,875 | — | $4.70 |
| Option | 180,000 | — | $2.35 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Insight Molecular Diagnostics Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.
Insight Molecular Diagnostics’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Ronald Andrews | President and Chief Executive Officer | $2,065,962 |
| William Annett · this page | Former President and Chief Executive Officer | $1,628,878 |
| Lyndal Hesterberg | Chief Scientific Officer (5) | $1,216,810 |
| Mitchell Levine | Chief Financial Officer | $1,157,937 |
| Albert Parker | Chief Operating Officer (15) | $911,353 |
| Padma Sundar | Senior Vice President, Marketing and Market Access (12) | $773,923 |
The full Insight Molecular Diagnostics compensation record
free company briefThis page is one person within Insight Molecular Diagnostics's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Insight Molecular Diagnostics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.